Hoyle, Martin - In: PharmacoEconomics 26 (2008) 7, pp. 589-602
Background: Cost-effectiveness analyses worldwide assume that the price of any single drug increases with inflation. New guidance from the Pharmaceutical Management Agency in New Zealand suggests that, when it is known that a generic drug will be available in the near future, a best estimate of...